avatrombopag (Doptelet)
Jump to navigation
Jump to search
Indications
- thrombocytopenia in patient with chronic liver disease who are to undergo a planned medical or dental procedure
Mechanism of action
- thrombopoietin receptor agonist
- stimulates platelet production
More general terms
References
- ↑ Brooks M FDA OKs Platelet Booster for Liver Disease Patients . Medscape - May 21, 2018 https://www.medscape.com/viewarticle/897029